KRT18 and myeloid sarcoma: Therefore, the recombinant SU of HERV-K18 was studied for its ability to induce proliferation of T cells, to elicit specific IgG titers in immunized mice, and to provoke symptoms of experimental autoimmune encephalomyelitis (EAE), the classic mouse model for MS, in challenged mice.